Finding suggests need for multifront therapeutic approach
Notable cohort findings include abnormal saccadic eye movements, use of second-line DMTs
What neurologists need to know about this emerging development
Dr. Robert Fox puts a tissue marker study in context
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Applications in MS, neurodegenerative disease and epilepsy
Paves way for phase 3 testing of novel treatment approach
$10.6M award to help compare escalation with early highly effective treatment
Dr. Jeffrey Cohen on the challenges that temper the promise
New Lancet review brings specialists, generalists up to speed
Enabling them to cough reduces their pneumonia risk
Advertisement
Advertisement